Protalix Biotherapeutics, Inc. (PLX)
1.785
+0.04
(+2.00%)
USD |
NYAM |
Dec 24, 12:43
Protalix Biotherapeutics Cash from Operations (Annual): 8.674M for Dec. 31, 2024
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| PAVmed, Inc. | -33.55M |
| AIM ImmunoTech, Inc. | -14.89M |
| Perspective Therapeutics, Inc. | -18.29M |
| Electromed, Inc. | 11.39M |
| Armata Pharmaceuticals, Inc. | -37.55M |